ARTICLE | Company News
SciClone, Schering-Plough infectious news
April 17, 2006 7:00 AM UTC
SCLN and SGP resolved a dispute related to trials of SCLN's Zadaxin to treat HBV that were run by SGP's Schering Plough KK subsidiary. In its 2005 annual report, SCLN said it cannot seek Japanese app...